JeffreyLBerenbergMDMACP

Oncology • Tripler Army Medical Center, HI

Hematologic Oncology

Professor University of Hawaii Cancer Center Hematologist Oncologist at Tripler Army Medical Center

Join to view full profile

Dr. Berenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Berenberg's full profile

Already have an account?

Office
1 Jarrett White Rd
Mchk-Dmo, Tamc
Tripler Army Medical Center, HI 96859
Phone+1 808-433-4089

Fax+1 808-433-2707
Is this information wrong?

Education & Training

Brigham and Women's HospitalResidency, Internal Medicine, 1968 - 1970
Boston University School of MedicineClass of 1968

Certifications & Licensure

HI State Medical License 1996 - 2026
MD State Medical License 1972 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Paclitaxel in Treating Patients With Ovarian Stromal Cancer Start of enrollment: 2000 Nov 20
Completed
Phase 2
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer Start of enrollment: 2006 Jun 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Start of enrollment: 2006 Oct 01
Completed
Phase 3
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
Active, not recruiting
Phase 3
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma Start of enrollment: 2008 Apr 01
Active, not recruiting
Phase 3
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2009 Jul 02
Completed
Phase 2
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer Start of enrollment: 2010 Apr 01
Completed
Phase 2
Acute Pain Caused by Paclitaxel in Patients With Cancer Start of enrollment: 2009 Feb 01
Completed
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
Active, not recruiting
Phase 2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Home-Based Programs for Improving Sleep in Cancer Survivors Start of enrollment: 2010 Apr 01
Terminated
Phase 2
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnos Start of enrollment: 2011 Jan 01
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Feb 01
Terminated
Phase 3
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
Completed
Not Applicable
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Start of enrollment: 2010 Jun 01
Completed
Phase 3
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 2011 Jan 07
Completed
Phase 2
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma Start of enrollment: 2010 May 01
Completed
Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy Start of enrollment: 2011 Apr 01
Completed
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Start of enrollment: 2010 Oct 15
Completed
Phase 2
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance Start of enrollment: 2011 Jan 01
Completed
Phase 3
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Active, not recruiting
Phase 2
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy Start of enrollment: 2011 Jul 01
Completed
Phase 2
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01
Completed
Phase 2
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma Start of enrollment: 2013 Jun 01
Completed
Phase 3
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20
Active, not recruiting
Phase 2
S1204, Viral Screening in Newly Diagnosed Cancer Patients Start of enrollment: 2013 Aug 29
Completed
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Start of enrollment: 2014 Feb 14
Terminated
Phase 2
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Start of enrollment: 2014 Mar 21
Completed
Phase 3
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Active, not recruiting
Phase 3
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Start of enrollment: 2014 May 01
Terminated
Phase 3
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11.
Vered Stearns, Opeyemi A Jegede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilm...> ;Clinical Cancer Research. 2024 Apr 19
Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program.
Christa M Braun-Inglis, Emily V Dressler, Jamie S Myers, Al B Benson 3rd, Marie Flannery, Marjorie Good, Andrea Denicoff, Jeffrey L Berenberg, Alisha T DeTroye, Bridge...> ;JCO Oncology Practice. 2024 Feb 1
An Unusual Presentation of SCAD in a Young Male Soldier.
Oliver Lee, Kelly Sun, Elianna Goldstein, James Jang, Jeffrey Berenberg> ;Military Medicine. 2024 Feb 27
Pembrolizumab Induced Calcitriol-Mediated Hypercalcemia.
Tiffany T Oommen, Kelly Sun, Javier Barranco-Trabi, Jeffrey Berenberg, Myungjin Kim> ;Case Reports in Nephrology. 2023 Jan 1
Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials.
Gretchen Kimmick, Mina S Sedrak, Grant Williams, Nadine J McCleary, Ashley E Rosko, Jeffrey L Berenberg, Rachel A Freedman, Mary Lou Smith, Amina Ahmed, Hyman B Muss, ...> ;Journal of the National Cancer Institute. Monographs. 2022 Dec 15
2 citations
Enrolling Older Adults Onto National Cancer Institute-Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions.
Judith O Hopkins, Christa Braun-Inglis, Sofia Guidice, Meg Wells, Kiran Moorthi, Jeffrey Berenberg, Diane St Germain, Supriya Mohile, Matthew F Hudson> ;Journal of the National Cancer Institute. Monographs. 2022 Dec 15
2 citations
Overcoming racial disparities in cancer clinical trial enrollment of Asians and Native Hawaiians.
Jared D Acoba, Ken Sumida, Jeffrey Berenberg> ;Contemporary Clinical Trials Communications. 2022 Aug 1
Clinical Research Professional Providing Care Coordination Support: A Study of Hawaii Minority/Underserved NCORP Community Site Trial Participants.
Izumi Okado, Ian Pagano, Kevin Cassel, Anamalia Su'esu'e, Jessica Rhee, Jeffrey Berenberg, Randall F Holcombe> ;JCO Oncology Practice. 2022 Jul 1
Role of Oncology Advanced Practitioners to Enhance Clinical Research.
Christa Braun-Inglis, Leigh M Boehmer, Laura J Zitella, Brianna Hoffner, Yurii B Shvetsov, Jeffrey L Berenberg, Randall A Oyer, Al B Benson 3rd> ;Journal of the Advanced Practitioner in Oncology. 2022 Mar 1
A Rare Coexistence of Seminoma and Hodgkin's Lymphoma in Hawai'i.
Zhaohui Liao Arter, Sanket Meghpara, Salvatore Mignano, Jeffrey Berenberg> ;Hawai'i Journal of Health & Social Welfare. 2021 Dec 1
197 citations
Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study.
Supriya G. Mohile, Mostafa R. Mohamed, Huiwen Xu, Eva Culakova, Kah Poh Loh, Allison Magnuson, Marie Flannery, Spencer Obrecht, Nikesha Gilmore, Erika Ramsdale, Richar...> ;Lancet. 2021 Nov 20
12 citations
Caregiving burden of informal caregivers of older adults with advanced cancer: The effects of rurality and education.
Huiwen Xu, Sindhuja Kadambi, Supriya G. Mohile, Shuhan Yang, Lee Kehoe, Megan Wells, Eva Culakova, Charles Kamen, Spencer Obrecht, Mostafa R. Mohamed, Nikesha Gilmore,...> ;Journal of Geriatric Oncology. 2021 Apr 12
27 citations
Associations of Uncertainty With Psychological Health and Quality of Life in Older Adults With Advanced Cancer
Haydee Cristina Verduzco-Aguirre, Dilip Sankar Babu, Supriya G. Mohile, Javier Bautista, Huiwen Xu, Eva Culakova, Beverly Canin, Yingzi Zhang, Megan Wells, Ronald M. E...> ;Journal of Pain and Symptom Management. 2021 Feb 1
66 citations
Assessment of Financial Toxicity Among Older Adults With Advanced Cancer.
Asad Arastu, Arpan Patel, Supriya G. Mohile, Joseph Ciminelli, Ramya Kaushik, Megan Wells, Eva Culakova, Lianlian Lei, Huiwen Xu, David W. Dougherty, Mostafa R. Mohame...> ;JAMA Network Open. 2020 Dec 1
58 citations
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
Kathy S. Albain, Robert Gray, Della F. Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, S...> ;Journal of the National Cancer Institute. 2021 Apr 6
7 citations
Relationships of self-perceived age with geriatric assessment domains in older adults with cancer
Kah Poh Loh, Paul R. Duberstein, Jason Zittel, Lianlian Lei, Eva Culakova, Huiwen Xu, Sandy Plumb, Marie Flannery, Allison Magnuson, Javier Bautista, Marsha N. Wittink...> ;Journal of Geriatric Oncology. 2020 Jul 1
University of Hawai'i Cancer Center Connection: University of Hawai'i Cancer Center: Collaboration Through Partnership with the National Cancer Institute.
Jared David Acoba, Jeffrey L. Berenberg> ;Hawai'i Journal of Health & Social Welfare. 2020 May 1
94 citations
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analys...
Joseph A. Sparano, Robert Gray, DF Makower, Kathy S. Albain, Thomas James Saphner, Sunil Badve, Lynne I. Wagner, Virginia G. Kaklamani, Maccon M. Keane, Henry L. Gomez...> ;JAMA Oncology. 2020 Mar 1
13 citations
Engaging older patients with cancer and their caregivers as partners in cancer research.
Nikesha Gilmore, Beverly Canin, Mary I. Whitehead, Margaret Sedenquist, Lorraine Griggs, Lynn Finch, Valerie Aarne Grossman, Valerie Targia, Megan Wells, Charles Kamen...> ;Cancer. 2019 Dec 1
40 citations
Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults.
Kah Poh Loh, Supriya G. Mohile, Ronald M. Epstein, Colin McHugh, Marie Flannery, Eva Culakova, Lianlian Lei, Megan Wells, Nikesha Gilmore, Dilip Sankar Babu, Mary I. W...> ;Cancer. 2019 Jul 15
284 citations
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Joseph A. Sparano, Robert Gray, Peter M. Ravdin, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Ma...> ;The New England Journal of Medicine. 2019 Jun 3
3 citations
Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy.
Ian R. Kleckner, Charles Kamen, Jennifer S. Gewandter, Nimish Mohile, Charles E. Heckler, Eva Culakova, Chunkit Fung, Michelle C. Janelsins, Matthew Asare, Po-Ju Lin, ...> ;Supportive Care in Cancer. 2019 Jan 1
1251 citations
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Joseph A. Sparano, Robert Gray, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, J...> ;The New England Journal of Medicine. 2018 Jun 3
167 citations
Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Ian R. Kleckner, Charles Kamen, Jennifer S. Gewandter, Nimish Mohile, Charles E. Heckler, Eva Culakova, Chunkit Fung, Michelle C. Janelsins, Matthew Asare, Po-Ju Lin, ...> ;Supportive Care in Cancer. 2018 Apr 1
3 citations
Metronidazole caused profound drug-induced immune thrombocytopenia.
Jeffrey L. Berenberg> ;Clinical Case Reports. 2018 Jan 1
Join now to see all

Abstracts/Posters

The Mystery of Magic Blood _ Familial Macrothrombocytopenia Associated with a Novel Variant in GP1BA Gene
Jeffrey L. Berenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
American College of Physicians - ACP
Fellow